Clin2
NCT07223658Possibly a fitRecruiting

Study of ARO-DIMERPA for high triglycerides and cholesterol

Hyperlipidemia; Mixed

Part of Genetic & congenital, Hormones & metabolism clinical trials.

This trial tests an experimental drug, ARO-DIMERPA, for people with very high triglycerides and cholesterol. It aims to lower those levels and reduce heart risks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
78 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be willing to follow diet advice from your doctor.
  • Your fasting triglycerides, LDL cholesterol, and other fat levels must be above certain limits.
  • If you could have a baby, you must use effective birth control plus a condom, and not donate sperm or eggs during the study and for 90 days after.
  • You cannot have used certain RNA-based drugs or PCSK9 inhibitors recently.
  • You must not have uncontrolled high blood pressure, a bleeding disorder, or nephrotic syndrome.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07028749Recruiting· Phase 2
Study of an experimental drug for high triglycerides and remnant cholesterol

This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.

Anniston, Alabama
NCT06797401Recruiting· Phase 2
RBD5044 for mixed high cholesterol and triglycerides

This trial tests a new medication called RBD5044 for people with mixed dyslipidemia (high levels of fats and cholesterol in the blood). It may help lower triglycerides and cholesterol when statins aren't enough.

Lund
NCT07349615Recruiting· Phase 3
Study of SHR-1918 for high triglycerides

This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.

Shanghai, Shanghai Municipality
NCT07680829Not yet recruiting· Phase 3
New drug for very high triglycerides

This study tests a new medicine called DR10624 to see if it can lower very high levels of triglycerides (a type of fat in the blood) in people who have not been helped enough by standard treatments. The study compares the new drug to a placebo (a dummy shot) over several months.

Beijing
NCT06750341Not yet recruiting· Phase 2
Study of a new drug for high cholesterol

This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.

NCT07229937Recruiting· Phase 2
Testing an experimental drug for high cholesterol

This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.

Harbin, Heilongjiang

Hear when a new Hyperlipidemia; Mixed trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.